Abstract
In this report, we present structural data for the murine Xist gene. The data presented in this paper demonstrate that the murine Xist transcript is at least 17.4 kb, not 14.3 kb as previously reported. The new structure of the murine Xist gene described herein has seven exons, not six. Exon VII encodes an additional 3.1 kb of information at the 3′ end. Exon VII contains seven possible sites for polyadenylation; four of these sites are located in the newly discovered 3′ end. Consequently, it is possible that several distinct transcripts may be produced through differential polyadenylation of a primary transcript. Alternative use of polyadenylation signals could result in size changes for exon VII. Two major species of Xist are detectable by Northern analysis, consistent with differential polyadenylation. In this paper, we propose a model for the role of the Xist 3′ end in the process of X-chromosome counting and choice during embryonic development.
Female mammals are mosaic for expression of X-linked genes with the clonal random silencing of gene expression from one X-chromosome (1–5). The process of murine X-chromosome inactivation is thought to involve not only the gene Xist (X inactive specific transcript) but also a locus called the Xce (X controlling element) (6, 7). Molecular, cellular, and transgenic evidence unequivocally proves that Xist is necessary for X-chromosome inactivation (8–11). The minimum genomic interval that recapitulates the phenomenon of X-chromosome counting, choice, and silencing can be encompassed on a 40-kb cosmid that contains 9 kb upstream and 6 kb downstream of Xist (10). In this report, we demonstrate that the widely disseminated structure for the murine Xist gene must be revised. The gene encodes a transcript that is larger than 14.3 kb. We further demonstrate that there are seven exons, not six. Finally, we show that an additional exon is found at the 3′ end and is located within the region shown to play a role in X-chromosome choice/counting (7, 12, 13).
Transgenic studies of X-chromosome inactivation have provided two conflicting lines of evidence. The first line of evidence would suggest that a cosmid spanning Xist encodes information to direct the process of X-chromosome inactivation (10). These complementation studies showed that in male embryonic stem cells, an ectopic Xist cosmid was essential for control of counting, choice, and silencing of a reporter gene. The other line of evidence, using the cre/lox deletional technology (12), would support the existence of another locus responsible for choice and counting. In these experiments, a 65-kb deletion downstream of Xist was shown to alter the transcript stability as well as the “choice” mechanism of X-chromosome inactivation. The Xist cosmid contained 6 kb of DNA downstream of the known 3′ end of Xist. The proximal cre/lox deletion site is within this 6-kb interval, 1 kb from the 3′ end of Xist (as described by Brockdorff et al., ref. 14). The data from this report may reconcile these apparent contradictions by redefining the structure of Xist.
EXPERIMENTAL PROCEDURES
Reagents.
YAC116 (9) was used as a genomic DNA control for all the PCR reactions. cDNA libraries were obtained as follows: female mouse lung (Stratagene, Catalogue no. 936307), female mouse brain (Stratagene, Catalogue no. 937319), female mouse uterus (CLONTECH, Catalogue no. ML1022B), male mouse brain (CLONTECH, Catalogue no. ML3000B), male mouse heart (CLONTECH, Catalogue no. ML1048B), mouse lung (CLONTECH, Catalogue no. ML1046B), and mouse testis (CLONTECH, Catalogue no. ML1020B). DNA sequences of the oligonucleotides used in this study are listed in Table 1.
Table 1.
Oligonucleotides | Location | DNA sequences (5′ to 3′) |
---|---|---|
WS758 | Exon 7 | CATTTCCTCATTGAAGTGAATTG |
WS770 | Exon 7 | AAACAAGAATTCACTAAGGATAGAAGC |
WS780 | Exon 6 | AATACACAATGCCATCTACCAAATATTA |
WS812 | EST1 | TCCAGCCTTCTGAGTAAATATT |
WS813 | EST1 | CCTCTTTTATTATTTCCACTCTA |
WS814 | EST2 | GATGCTAAGTGCAACACAT |
WS815 | EST2 | TCACAGTCATAGCTAAAATGG |
WS816 | EST3 | GGGTGGGACAGGAGGCCG |
WS817 | EST3 | AGATGATGGTAGGATGTGCTT |
WS818 | EST4 | AGACTGGAGTCATCTTCCC |
WS821 | EST4 | CAAACTACCCCACCCACTC |
WS831 | Old Xist end | CTTTGCTTTTATCCCAGGCA |
WS832 | EST1 | CACTTTGGGTTGCATCCTTT |
WS833 | EST1 | ATTTGTTCATTGCCTGGCTC |
WS834 | EST2 | TCACACTGAGTGCCCTTTTG |
WS835 | EST2 | GCTTTGTAGCAAGCCTGACC |
WS836 | EST3 | TTCAACCTGGCTCCATCTTC |
WS837 | EST3 | GAAGATGGAGCCAGGTTGAA |
WS838 | EST4 | ATCCGTTCACAAAGTCCAGG |
WS852 | Downstream of EST4 | GCTGGCCTACACGGGTATAA |
PCR Amplification and Cloning.
DNA fragments containing exons 6 and 7 were amplified either from YAC116 by using WS780 and WS758 or from the female mouse lung cDNA library by using WS780 and WS770. Each fragment was cloned into the pGEM-T vector (Promega), resulting in pWS850 and pWS873, respectively. Expressed Sequence Tag (EST) fragments were recovered from either YAC116, female mouse lung, male mouse brain, or male heart cDNA libraries by using the following primers: pWS811/WS813 for Xist + EST1, pWS812/WS815 for EST1 + EST2, pWS835/WS836 for EST2 + EST3, pWS837/WS838 for EST3 + EST4. These fragments were cloned into pBluescript II SK+ (Stratagene), resulting in pWS848, pWS849, pWS854, and pWS855, respectively. The individual ESTs were PCR amplified by using pWS812/WS813 (EST1), pWS814/WS815 (EST2), pWS816/WS817 (EST3), and pWS818/WS821 (EST4) and cloned into pBluescript II SK+, resulting in pWS857, pWS858, pWS859, and pWS860, respectively. All the cloned materials were sequenced by using T3 and T7 primers by the Beth Israel Deaconess Medical Center sequencing facility on an Applied Biosystems 377 sequencer.
DNA Blotting.
Duplicate gels containing the PCR products with the primers, WS831/WS832 (Xist + EST1), WS833/WS834 (EST1 + EST2), WS835/WS836 (EST2 + EST3) and WS837/WS838 (EST3 + EST4) were transferred to nylon membrane and hybridized with probes spanning the 5′ and 3′ end of each fragment. Thus, Xist + EST1 was probed with both the Xist probe and the EST1 probe; EST1 + EST2, EST2 + EST3, and EST3 + EST4 fragments were analyzed similarly. The 270-bp product from a PstI/BglII digestion of pWS850 was used as the probe for the 3′ region of Xist; probes for EST1, 2, 3, and 4 were prepared from BamHI/SalI digestions of pWS857, pWS858, pWS859, and pWS860, respectively. All the probes were radiolabeled by the random hexamer labeling method (15) in the presence of [32P]dCTP and hybridized for 12–24 hr at 65°C in a buffer containing 7% SDS, 2 mM EDTA (pH 7.6), and 0.5 M sodium phosphate (pH7.5).
Northern Blot Analysis.
Total RNA was isolated by using the guanidinium thiocyanate method from kidneys of male and female mice (16). Total RNA was electrophoresed on 0.8% agarose gel containing 2.2 M formaldehyde for 16 hr at 100 V and then transferred to positively charged nylon, yielding duplicate matched lanes. Then, blots were hybridized with 32P-labeled DNA fragments from either SacII/SacI digestion of pWS850 or ClaI/EcoRI of pWS854 (see Fig. 3).
RNA–Fluorescence in Situ Hybridization (FISH).
Male and female fibroblasts were isolated from normal mice, grown on chamber slides, and fixed as described (17). Two plasmids were used as probes for RNA-FISH: EST 2/3 (pWS854, digoxygenin) or exons VI–VII (pWS850, biotin) (see Fig. 2A). Probes were hybridized either separately or simultaneously to the interphase spreads of murine male and female dermal fibroblasts. After washing, the spreads were labeled with antidigoxygenin rhodamine or avidin-fluorescein. Images were collected with a Nikon E-800 microscope equipped with a Sensys (Photometrics, Tucson, AZ) digital CCD camera. Grayscale images for either FITC, rhodamine, or 4′,6-diamidino-2-phenylindole filter sets were pseudocolored and images were merged in the 12-bit format. The 12-bit data were compressed as 8-bit data during export to Photoshop 5.0 (Adobe Systems, Mountain View, CA) for final figure preparation (Fig. 4).
RESULTS
We examined the Xist transcript (GenBank accession no. L04961) and genomic sequence (GenBank accession no. U41394). This review brought to light discrepancies and required that the organization of the Xist gene be reevaluated. The predicted size and sequence of the established exon VI was in fact not in agreement with the apparent cDNA structure. The genomic sequence would have predicted that an additional 781 bp of sequence should be part of the cDNA. Cloning and sequencing the relevant regions from both the genomic and cDNA derived from PCR-amplified templates confirmed that this genomic sequence was absent in the cDNA (see Fig. 1 A and B). Consistent with this difference, splice donor and splice acceptor sequences could be identified. Despite the published (14) structure of Xist, the only logical conclusion was that exon VI was in fact two exons. These exons are therefore renamed exon VI and exon VII. Exon VI is 155 bp long.
A survey of the EST database was also conducted. During this survey, all mouse ESTs were mapped to the 94-kb sequence spanning the mapped location of the Xce (GenBank accession no. X99946). We determined that there were four ESTs that mapped between the published 3′ end of Xist and Tsx (see Fig. 2A and notes). In fact, all four of these female-specific ESTs were within 3.1 kb of the 3′ end of Xist, and no other EST sequences were observed to map to this interval. Further examination of these four female-specific ESTs revealed that they did not encode any significant ORFs as indicated by the DNA strider program. In an effort to relate the significance of these ESTs to Xist, we constructed a series of PCR primers that spanned either the individual EST sequence, the 3′ end of Xist and EST1 (X + EST1), EST1 + EST2, EST2 + EST3, or EST3 + EST4. These primers were then used to screen cDNA libraries constructed from RNA derived from murine male or female soma. In particular, the female cDNA library was the one used to originally define the murine Xist structure (14). When primers spanning Xist and EST1 (X + EST1) were used, only a female-specific product was isolated (Fig. 2B). This result demonstrates the colinearity of Xist transcript with EST1. The isolation of female-specific PCR products for the combinations of primers termed EST1 + EST2, EST2 + EST3, EST3 + EST4 was also observed. These results demonstrate the colinearity of all the ESTs with each other and with Xist transcript. Our conclusion from these data was that the murine Xist transcript was in fact larger than originally defined, extending into the genomic region demarked by EST1–EST4.
We wished to determine whether sequences downstream of EST4 were also incorporated into the Xist transcript. Two sets of PCR primers were used in combination to attempt to recover cDNA material from three female as well as four male cDNA libraries (see Fig. 2A and data not shown). No products were detected in these experiments.
No size difference between genomic or cDNA template was observed with primers spanning Xist + EST1, EST1 + EST2, EST2 + EST3, EST3 + EST4. All PCR products were subject to complete sequence analysis. The results of this analysis confirmed that the PCR products were in fact derived from the region spanned by EST1–EST4. Several interesting structural features were observed: four additional polyadenylation signals, as well as two potential stem loops. This suggested that the Xist transcript was not only extending into the EST1–EST4 region, but that the portion of the transcript derived from this region could be differentially processed; however, no evidence for differential splicing was observed (see Fig. 2B).
To determine the size and complexity of the Xist transcript(s) encompassing the new 3′ end, Northern blots were used. Somatic RNA was extracted from murine female and male kidney. After fractionation on denaturing agarose gels, the resulting blots were hybridized either to a probe corresponding to exons VI–VII (pWS850) or to a probe corresponding to the region spanned by EST2 and 3 (pWS854) (see Fig. 3). The figure shows two major species of Xist using the pWS850 probe. The new 3′-end probe, pWS854, hybridizes disproportionately to the larger of the two major species of Xist RNA.
RNA–FISH was performed to determine whether the new 3′ end colocalized with the established sequences of the murine Xist transcript on the inactive X-chromosome found in female cells (see Fig. 4). The same two DNA probes used for Northern analysis were used in this experiment. The data from these experiments show that the probe (pWS854) corresponding to the 3′ end colocalizes with the rest of the Xist transcript (pWS850) on the inactive X-chromosome. Thus the new 3′ end of the murine Xist gene is associated with Xist molecules, which correctly localize in a functionally significant manner.
DISCUSSION
One conclusion of the data presented here is a redefinition of the exonic/intronic structure of Xist. The cDNA, as originally described (14), was thought to be composed of six exons. The genomic sequence deposited in GenBank shows splice donor/acceptor sites consistent with a seventh exon. Here we demonstrate that these putative signals are used, and the segment thought to encode exon VI is actually encoded by two exons that we have labeled VI and VII, the existence of this exon proven by comparison of cloned cDNA with cloned genomic DNA. The reassignment of exon VI into exons VI and VII does not greatly alter our understanding of Xist.
Another conclusion of the current report is the observation that the newly defined exon VII contains at least an additional 3.1-kb colinear sequence. In previous studies, EST and genomic sequence comparisons between the mouse and human Xist locus have suggested alternative structures for the murine Xist gene. One such study suggested that the mouse Xist gene contained a small distinct 3′ exon homologous to the human Xist eighth exon (18). In this same study, no evidence was found for a seventh exon. The data collected in the current study show no evidence for a distinct “eighth” exon in the major Xist transcript. Sequence analysis reveals at most seven polyadenylation sites 3′ of exon VI. Thus the structure of the Xist gene described here is consistent with a number of differential patterns of polyadenylation. Alternative use of polyadenylation signals could result in size changes for exon VII.
Consistent with our database and sequence evaluations, Northern analysis demonstrates that the major murine Xist transcript is longer than previously considered (14, 19). One of the two major Xist species hybridizes strongly to sequences previously identified with Xist (pWS850) as well as to the new sequences reported in this paper (pWS854). As expected, the 5′-probe, mx8 (20), failed to hybridize to the major murine somatic Xist transcripts (data not shown).
RNA–FISH experiments have produced results that show that transcripts containing the new 3′ end colocalize with transcripts containing the more 5′-exons. This colocalization supports the conclusion that the new 3′ end of the murine Xist gene is part of the functional transcript that has been demonstrated to be necessary for X-chromosome inactivation (8–11).
The current revision of Xist gene structure to include the addition of an enlarged exon VII alters the interpretation of the results from cre/lox deletional studies (12). The Xist proximal loxP (see Fig. 2A) site thought to lie distal to the 3′ end of Xist (14) in fact interrupts the Xist transcript in the EST1 region before the fourth polyadenylation signal (see Fig. 2A). Furthermore, it was established in these cre/lox transgenic studies that deletions altered Xist expression level in embryonic stem cells and somatic cells, as well as choice of Xic to undergo cis inactivation. In embryonic stem cells, expression of a 3′-deleted Xist allele is virtually undetectable despite the fact that the promoter region is untouched (20). This same allele is highly expressed and is always chosen in differentiated embryonic stem cells (12). Thus, exclusive choice of the deleted Xist allele may be caused by the loss of sequence at its 3′ end. This loss of sequence could alter mRNA stability. A change in Xist stability has been hypothesized to act as a trigger in the process of cis-inactivation (21, 22). The production of a transcript stabilized at the 3′ end may therefore be a rate-limiting step in both chromosome choice and initiation of cis-inactivation.
It is reasonable to consider that the observed transgenic phenomena are caused, at least in part, by the alteration in Xist genomic structure. However, other models are possible. In the reported deletion (12) there may be additional genes, regions, or elements critical for Xist stability and X-chromosome choice/counting. Only a revised functional analysis of the region 3′ to Xist will resolve the issue.
Acknowledgments
The authors acknowledge the extraordinary support of Dr. Fred Rosen and the Center for Blood Research, Harvard Medical School. We also thank Dr. Woo-Joo Song for his generous assistance. The authors also thank Drs. Philip Leder and George Church for critical review of this manuscript. This work was supported by a U.S. Army Prostate Cancer Research Award (PC970479), the Harvard Nathan Shock Center for Biology of Aging Core C, Harvard Medical School (5 P30 AG13314), the Harvard Milton Fund, and a Beth Israel Deaconess New Investigator Award, all awarded to W.M.S.
ABBREVIATIONS
- EST
expressed sequence tag
- FISH
fluorescence in situ hybridization
Footnotes
This paper was submitted directly (Track II) to the Proceedings Office.
References
- 1.Goto T, Monk M. Microbiol Mol Biol Rev. 1998;62:362–378. doi: 10.1128/mmbr.62.2.362-378.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Heard E, Avner P. Hum Mol Genet. 1994;3:1481–1485. doi: 10.1093/hmg/3.suppl_1.1481. [DOI] [PubMed] [Google Scholar]
- 3.Heard E, Clerc P, Avner P. Annu Rev Genet. 1997;31:571–610. doi: 10.1146/annurev.genet.31.1.571. [DOI] [PubMed] [Google Scholar]
- 4.Lyon M F. Eur J Hum Genet. 1994;2:255–261. doi: 10.1159/000472369. [DOI] [PubMed] [Google Scholar]
- 5.Monk M. Dev Genet. 1995;17:188–197. doi: 10.1002/dvg.1020170303. [DOI] [PubMed] [Google Scholar]
- 6.Cattanach B M, Williams C E. Genet Res. 1972;19:229–240. doi: 10.1017/s001667230001449x. [DOI] [PubMed] [Google Scholar]
- 7.Simmler M-C, Cattanach B M, Rasberry C, Rougeulle C, Avner P. Mamm Genome. 1993;4:523–530. doi: 10.1007/BF00364788. [DOI] [PubMed] [Google Scholar]
- 8.Penny G D, Kay G F, Sheardown S A, Rastan S, Brockdorff N. Nature (London) 1996;379:131–137. doi: 10.1038/379131a0. [DOI] [PubMed] [Google Scholar]
- 9.Lee J T, Strauss W M, Dausman J A, Jaenisch R. Cell. 1996;86:83–94. doi: 10.1016/s0092-8674(00)80079-3. [DOI] [PubMed] [Google Scholar]
- 10.Herzing L B K, Romer J T, Horn J M, Ashworth A. Nature (London) 1997;386:272–275. doi: 10.1038/386272a0. [DOI] [PubMed] [Google Scholar]
- 11.Marahrens Y, Panning B, Dausman J, Strauss W, Jaenisch R. Genes Dev. 1997;11:156–166. doi: 10.1101/gad.11.2.156. [DOI] [PubMed] [Google Scholar]
- 12.Clerc P, Avner P. Nat Genet. 1998;19:249–253. doi: 10.1038/924. [DOI] [PubMed] [Google Scholar]
- 13.Cattanach B M. Mouse News Letter. 1972;47:33. [Google Scholar]
- 14.Brockdorff N, Ashworth A, Kay G F, McCabe V M, Norris D P, Cooper P J, Swift S, Rastan S. Cell. 1992;71:515–526. doi: 10.1016/0092-8674(92)90519-i. [DOI] [PubMed] [Google Scholar]
- 15.Feinberg A P, Vogelstein B. Anal Biochem. 1983;132:6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
- 16.Chirgwin J M, Przybyla A E, MacDonald R J, Rutter W J. Biochemistry. 1979;18:5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
- 17.Trask B J. Trends Genet. 1991;7:149–154. doi: 10.1016/0168-9525(91)90378-4. [DOI] [PubMed] [Google Scholar]
- 18.Simmler M C, Cunningham D B, Clerc P, Vermat T, Caudron B, Cruaud C, Pawlak A, Szpirer C, Weissenbach J, et al. Hum Mol Genet. 1996;5:1713–1726. doi: 10.1093/hmg/5.11.1713. [DOI] [PubMed] [Google Scholar]
- 19.Brockdorff N, Ashworth A, Kay G F, Cooper P, Smith S, McCabe V M, Norris D P, Penny G D, Patel D, Rastan S. Nature (London) 1991;351:329–331. doi: 10.1038/351329a0. [DOI] [PubMed] [Google Scholar]
- 20.Johnston C, Nesterova T B, Formstone E J, Newall A E T, Duthie S M, Sheardown S A, Brockdorff N. Cell. 1998;94:809–817. doi: 10.1016/s0092-8674(00)81739-0. [DOI] [PubMed] [Google Scholar]
- 21.Panning B, Dausman J, Jaenisch R. Cell. 1997;90:907–916. doi: 10.1016/s0092-8674(00)80355-4. [DOI] [PubMed] [Google Scholar]
- 22.Sheardown S A, Duthie S M, Johnston C M, Newall A E T, Formstone E J, Arkell R M, Nesterova T B, Alghisi G-C, Rastan S, Brockdorff N. Cell. 1997a;91:99–107. doi: 10.1016/s0092-8674(01)80012-x. [DOI] [PubMed] [Google Scholar]